Plunkett Research Online: Sunesis Pharmaceuticals Inc

SUNESIS PHARMACEUTICALS INC (SNSS:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Sunesis Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. Its efforts are currently focused mainly on the development of vosaroxin for the treatment of acute myeloid .....



Sunesis Pharmaceuticals Inc
Ticker: SNSS
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 650 266-3500
Fax: 650 266-3505
Address: 395 Oyster Point Boulevard
Suite 400
South San Francisco, CA 94080 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
ContactsDescription
James YoungChairman of the Board/Director
William QuinnChief Accounting Officer/Senior VP, Divisional
See More
Sunesis Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. Its efforts are currently focused mainly on the development of vosaroxin for the treatment of acute myeloid .....See More See More

Auditor: ERNST & YOUNG, LLP
Legal Advisor: Cooley LLP
$USD, In whole numbers,
except marked * or %
201620152014201320122011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: